Inventor
GORIN BORIS
IL32 patents
⚠️ This page may combine multiple inventors who share the name “GORIN BORIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALPHORA RES INC
9 patentsUS9278979B2Mar 8, 2016
Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
ALPHORA RES INC21 citations88
US9062020B2Jun 23, 2015
2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
ALPHORA RES INC2 citations60
US9650397B2May 16, 2017
3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
ALPHORA RES INC0 citations49
US9416140B2Aug 16, 2016
Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
ALPHORA RES INC0 citations49
US9181152B2Nov 10, 2015
Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene
ALPHORA RES INC0 citations49
US9174956B2Nov 3, 2015
Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
ALPHORA RES INC0 citations49
US9695187B2Jul 4, 2017
Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
ALPHORA RES INC1 citations48
US9758464B2Sep 12, 2017
Continuous flow process for the preparation of Ingenol-3-mebutate
ALPHORA RES INC0 citations43
US9850254B2Dec 26, 2017
Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groups
ALPHORA RES INC0 citations39
APOTEX INC
6 patentsUS10800787B2Oct 13, 2020
Process for the preparation of acalabrutinib
APOTEX INC9 citations81
US10183024B2Jan 22, 2019
Crystalline forms of ibrutinib
APOTEX INC2 citations71
US10513504B2Dec 24, 2019
Processes for the preparation of apalutamide and intermediates thereof
APOTEX INC2 citations70
US11072620B2Jul 27, 2021
Crystalline forms of Ponatinib hydrochloride
APOTEX INC0 citations59
US10351537B2Jul 16, 2019
Processes for the preparation of lesinurad and intermediates thereof
APOTEX INC0 citations39
US10556887B2Feb 11, 2020
Processes for the preparation of Veliparib and intermediates thereof
APOTEX INC0 citations36
AKEBIA THERAPEUTICS INC
4 patentsUS10738010B2Aug 11, 2020
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
AKEBIA THERAPEUTICS INC12 citations93
US9776969B2Oct 3, 2017
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
AKEBIA THERAPEUTICS INC22 citations93
US10246416B2Apr 2, 2019
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
AKEBIA THERAPEUTICS INC11 citations89
US11267785B2Mar 8, 2022
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
AKEBIA THERAPEUTICS INC5 citations82
PROOFPOINT ISRAEL LTD
3 patentsUS10581876B2Mar 3, 2020
Apparatus and methods thereof for inspecting events in a computerized environment respective of a unified index for granular access control
PROOFPOINT ISRAEL LTD2 citations68
US11671461B1Jun 6, 2023
Apparatus and methods thereof for inspecting events in a computerized environment respective of a unified index for granular access control
PROOFPOINT ISRAEL LTD0 citations58
US11489850B2Nov 1, 2022
Apparatus and methods thereof for inspecting events in a computerized environment respective of a unified index for granular access control
PROOFPOINT ISRAEL LTD0 citations58